UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Heparin cofactor II modulates the response to vascular injury

Arteriosclerosis, thrombosis, and vascular biology, 2007-03, Vol.27 (3), p.454

Tollefsen, Douglas M

2007

Link zum Volltext

Verfügbarkeit prüfen

α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis

PloS one, 2014-11, Vol.9 (11), p.e114035

2014

Link zum Volltext

Verfügbarkeit prüfen

The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption

Bone (New York, N.Y.), 2012-11, Vol.51 (5), p.902-912

2012

Link zum Volltext

Verfügbarkeit prüfen

Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient mice

Blood, 2007-12, Vol.110 (13), p.4261-4267

2007

Link zum Volltext

Verfügbarkeit prüfen

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II

Blood, 2008-04, Vol.111 (8), p.4118-4125

2008

Link zum Volltext

Verfügbarkeit prüfen

Heparin cofactor II inhibits arterial thrombosis after endothelial injury

The Journal of clinical investigation, 2002, Vol.109 (2), p.213-219

2002

Link zum Volltext

Verfügbarkeit prüfen

The contributions of the α2β1 integrin to vascular thrombosis in vivo

Blood, 2003-11, Vol.102 (10), p.3652-3657

2003

Link zum Volltext

Verfügbarkeit prüfen

Selective cleavage and anticoagulant activity of a sulfated fucan: stereospecific removal of a 2-sulfate ester from the polysaccharide by mild acid hydrolysis, preparation of oligosaccharides, and heparin cofactor II-dependent anticoagulant activity

Glycobiology (Oxford), 2005-04, Vol.15 (4), p.369-381

2005

Link zum Volltext

Verfügbarkeit prüfen

Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury

Blood, 2008-04, Vol.111 (8), p.4137-4144

2008

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice

Blood, 2004-12, Vol.104 (13), p.3965-3970

2004

Link zum Volltext

Verfügbarkeit prüfen

Proteolytic activation transforms heparin cofactor II into a host defense molecule

The Journal of immunology (1950), 2013-06, Vol.190 (12), p.6303-6310

2013

Link zum Volltext

Verfügbarkeit prüfen

Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants

Blood, 2005-05, Vol.105 (10), p.3902-3909

2005

Link zum Volltext

Verfügbarkeit prüfen

Does heparin cofactor II modulate atherosclerosis and restenosis?

Circulation (New York, N.Y.), 2004-06, Vol.109 (22), p.2682-2684

TOLLEFSEN, Douglas M

2004

Link zum Volltext

Verfügbarkeit prüfen

PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting

Journal of cardiovascular magnetic resonance, 2012-02, Vol.14 (S1), p.O41-O41, Article O41

2012

Link zum Volltext

Verfügbarkeit prüfen

Thrombin inhibitor perfluorocarbon nanoparticles for treatment and 19F tracking of acute thrombosis

Journal of cardiovascular magnetic resonance, 2010, Vol.12 (S1), p.O60, Article O60

2010

Link zum Volltext

Verfügbarkeit prüfen

Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis

Thrombosis research, 2012-10, Vol.130 (4), p.646-648

2012

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II

Blood, 2011-06, Vol.117 (23), p.6347-6354

2011

Link zum Volltext

Verfügbarkeit prüfen

Vascular Dermatan Sulfate and Heparin Cofactor II

Glycosaminoglycans in Development, Health and Disease, 2010, Vol.93, p.351-372

Tollefsen, Douglas M.

2010

Link zum Volltext

Verfügbarkeit prüfen

A Self-inactivating γ-Retroviral Vector Reduces Manifestations of Mucopolysaccharidosis I in Mice

Molecular therapy, 2010-02, Vol.18 (2), p.334-342

2010

Link zum Volltext

Verfügbarkeit prüfen

Heparin cofactor II deficiency

Archives of pathology & laboratory medicine (1976), 2002-11, Vol.126 (11), p.1394-1400

Tollefsen, Douglas M

2002

Link zum Volltext

Verfügbarkeit prüfen

Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II

Blood, 2006-04, Vol.107 (7), p.2753-2758

2006

Link zum Volltext

Verfügbarkeit prüfen

N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate

Glycobiology (Oxford), 2006-08, Vol.16 (8), p.693-701

2006

Link zum Volltext

Verfügbarkeit prüfen

Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli

Analytical biochemistry, 2010-11, Vol.406 (2), p.166-175

2010

Link zum Volltext

Verfügbarkeit prüfen

Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II

The Journal of biological chemistry, 2002-03, Vol.277 (9), p.6788

2002

Link zum Volltext

Verfügbarkeit prüfen

Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in mice

Cytotherapy (Oxford, England), 2011-07, Vol.13 (6), p.695-704

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(81)
Buchkapitel
(1)

Sprache

Englisch
(82)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Life Sciences & Biomedicine
(60)
Humans
(47)
Animals
(34)
Biological And Medical Sciences
(32)
Biochemistry & Molecular Biology
(31)
Hematology
(22)
Fundamental And Applied Biological Sciences. Psychology
(20)
Heparin Cofactor Ii - Metabolism
(19)
Thrombin - Metabolism
(19)
Thrombin - Antagonists & Inhibitors
(18)
Mice
(17)
Biochemistry
(16)
Molecular Sequence Data
(15)
Amino Acid Sequence
(14)
Cell Biology
(14)
Heparin Cofactor Ii
(14)
Binding Sites
(13)
Medical Sciences
(13)
Heparin Cofactor Ii - Genetics
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Heparin cofactor II modulates the response to vascular injury

α2β1 integrin, GPVI receptor, and common FcRγ chain on mouse platelets mediate distinct responses to collagen in models of thrombosis

The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption

Accelerated atherogenesis and neointima formation in heparin cofactor II–deficient mice

Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II

Heparin cofactor II inhibits arterial thrombosis after endothelial injury

The contributions of the α2β1 integrin to vascular thrombosis in vivo

Selective cleavage and anticoagulant activity of a sulfated fucan: stereospecific removal of a 2-sulfate ester from the polysaccharide by mild acid hydrolysis, preparation of oligosaccharides, and heparin cofactor II-dependent anticoagulant activity

Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury

Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice

Proteolytic activation transforms heparin cofactor II into a host defense molecule

Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants

Does heparin cofactor II modulate atherosclerosis and restenosis?

PPACK and Bivalirudin nanoparticles enable simultaneous imaging and potent inhibition of acute clotting

Thrombin inhibitor perfluorocarbon nanoparticles for treatment and 19F tracking of acute thrombosis

Thrombomodulin is required for the antithrombotic activity of thrombin mutant W215A/E217A in a mouse model of arterial thrombosis

Inhibition of antithrombin by Plasmodium falciparum histidine-rich protein II

Vascular Dermatan Sulfate and Heparin Cofactor II

A Self-inactivating γ-Retroviral Vector Reduces Manifestations of Mucopolysaccharidosis I in Mice

Heparin cofactor II deficiency

Placental dermatan sulfate: isolation, anticoagulant activity, and association with heparin cofactor II

N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate

Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli

Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II

Dermatan sulfate and bone marrow mononuclear cells used as a new therapeutic strategy after arterial injury in mice

Suchergebnisse filtern